And following on, any patient requests to continue with the medication will inevitably be futile and useless.
FDA are highly unlikely to approve the medication (imo) which means there will be no government or insurer subsidy, and private script will be the only way forward, which affects pricing which means the pharma can't survive, which means they will inevitably stop producing the drug.
Again, the sound of inevitability.
- Forums
- ASX - By Stock
- NEU
- ANAVEX MEETS ENDPOINTS PHASE2 RETT
ANAVEX MEETS ENDPOINTS PHASE2 RETT, page-135
- There are more pages in this discussion • 32 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
|
|||||
Last
$19.80 |
Change
0.300(1.54%) |
Mkt cap ! $2.528B |
Open | High | Low | Value | Volume |
$19.49 | $19.92 | $19.25 | $5.352M | 271.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1000 | $19.78 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$19.80 | 516 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1000 | 19.780 |
2 | 1143 | 19.750 |
1 | 1441 | 19.740 |
1 | 5505 | 19.720 |
3 | 3263 | 19.700 |
Price($) | Vol. | No. |
---|---|---|
19.820 | 1081 | 2 |
19.890 | 150 | 1 |
19.900 | 2000 | 1 |
19.940 | 1143 | 2 |
19.950 | 1948 | 2 |
Last trade - 16.10pm 17/06/2024 (20 minute delay) ? |
|
|||||
Last
$19.80 |
  |
Change
0.300 ( 0.98 %) |
|||
Open | High | Low | Volume | ||
$19.41 | $19.92 | $19.25 | 77870 | ||
Last updated 15.59pm 17/06/2024 ? |
Featured News
NEU (ASX) Chart |
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non Executive Director
Simon Kidston
Non Executive Director
SPONSORED BY The Market Online